Brian joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015. Most recently, he served as Teva's Executive Vice President and Interim Global Chief Legal Officer. During his tenure, he also led Teva's global litigation strategy and served as General Counsel for its U.S. Generics business.

Prior to joining Teva, Brian practiced law at Dechert LLP. Brian brings extensive experience navigating the complex legal and regulatory landscape in the global pharmaceutical industry. He holds a Juris Doctor (J.D.) from Yale Law School and a B.A., summa cum laude, from the University of Pennsylvania.